Vitrafy Life Sciences (ASX:VFY) has entered a 12-month exclusive collaboration and development agreement with global animal reproduction leader IMV Technologies, SA, a French multinational responsible for over 500 million animal inseminations annually.
The partnership will integrate Vitrafy’s next-generation nitrogen-free cryopreservation technology with IMV’s established reproductive solutions, aiming to jointly commercialise a global offering for farm animals and aquaculture.
Under the agreement, Vitrafy will receive up to $480,000 per month, with potential milestone payments of $450,000, while providing key hardware, software, and service support for pre-commercialisation activities.
Both companies will contribute resources to validate and deploy the technology, with the goal of establishing a long-term commercial agreement following the successful 12-month program.